
Suzanne Marie Noakes
Examiner (ID: 8754, Phone: (571)272-2924 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1752 |
| Issued Applications | 1110 |
| Pending Applications | 203 |
| Abandoned Applications | 459 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18020952
[patent_doc_number] => 20220372451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI
[patent_app_type] => utility
[patent_app_number] => 17/729120
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729120 | PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI | Apr 25, 2022 | Abandoned |
Array
(
[id] => 19650054
[patent_doc_number] => 12171814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same
[patent_app_type] => utility
[patent_app_number] => 18/287223
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 9097
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287223
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287223 | Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same | Apr 17, 2022 | Issued |
Array
(
[id] => 18620633
[patent_doc_number] => 11753661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Process for the biological production of methacrylic acid and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/720739
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 29
[patent_no_of_words] => 24807
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720739 | Process for the biological production of methacrylic acid and derivatives thereof | Apr 13, 2022 | Issued |
Array
(
[id] => 19234083
[patent_doc_number] => 20240191275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PURIFICATION OF PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/554513
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554513 | PURIFICATION OF PROTEINS | Apr 10, 2022 | Pending |
Array
(
[id] => 17897335
[patent_doc_number] => 20220306997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/711270
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711270 | GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION | Mar 31, 2022 | Pending |
Array
(
[id] => 19265340
[patent_doc_number] => 20240209039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => NOVEL POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES AND USE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 18/285732
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285732
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285732 | NOVEL POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES AND USE FOR SAME | Mar 22, 2022 | Pending |
Array
(
[id] => 17720437
[patent_doc_number] => 20220213157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/656221
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656221 | Electrical conductors and methods of conducting ions using calsequestrin proteins | Mar 22, 2022 | Issued |
Array
(
[id] => 19768466
[patent_doc_number] => 20250049892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => SEMAGLUTIDE SOLUBLE MICRONEEDLE COMPOSITION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/722038
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722038
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722038 | SEMAGLUTIDE SOLUBLE MICRONEEDLE COMPOSITION AND PREPARATION METHOD THEREFOR | Mar 16, 2022 | Pending |
Array
(
[id] => 17852255
[patent_doc_number] => 20220282297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E
[patent_app_type] => utility
[patent_app_number] => 17/697043
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697043 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | Mar 16, 2022 | Pending |
Array
(
[id] => 17688109
[patent_doc_number] => 20220195401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => MODIFIED PIGGYBAC TRANSPOSASE POLYPEPTIDE, POLYNUCLEOTIDE ENCODING THEM, INTRODUCING CARRIER, KIT, METHOD OF INCORPORATING TARGET SEQUENCE INTO CELL GENOME, AND METHOD OF PRODUCING CELL
[patent_app_type] => utility
[patent_app_number] => 17/692857
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692857 | Modified piggyBac transposase polypeptide, polynucleotide encoding them, introducing carrier, kit, method of incorporating target sequence into cell genome, and method of producing cell | Mar 10, 2022 | Issued |
Array
(
[id] => 17850528
[patent_doc_number] => 20220280569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/691778
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691778 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Mar 9, 2022 | Issued |
Array
(
[id] => 19778755
[patent_doc_number] => 12227779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA
[patent_app_type] => utility
[patent_app_number] => 17/690657
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 47629
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690657 | Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA | Mar 8, 2022 | Issued |
Array
(
[id] => 17671020
[patent_doc_number] => 20220184187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => Combination treatment for atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 17/687789
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687789 | Combination treatment for atopic dermatitis | Mar 6, 2022 | Abandoned |
Array
(
[id] => 18182839
[patent_doc_number] => 20230043569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN
[patent_app_type] => utility
[patent_app_number] => 17/683123
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683123 | PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN | Feb 27, 2022 | Pending |
Array
(
[id] => 19354324
[patent_doc_number] => 12054755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/683299
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 10164
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683299 | None | Feb 27, 2022 | Issued |
Array
(
[id] => 17665506
[patent_doc_number] => 11359187
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-14
[patent_title] => Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
[patent_app_type] => utility
[patent_app_number] => 17/680279
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 26596
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680279 | Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells | Feb 23, 2022 | Issued |
Array
(
[id] => 19043807
[patent_doc_number] => 11932894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Method for producing albicanol and/or drimenol
[patent_app_type] => utility
[patent_app_number] => 17/673465
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20895
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673465 | Method for producing albicanol and/or drimenol | Feb 15, 2022 | Issued |
Array
(
[id] => 19043807
[patent_doc_number] => 11932894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Method for producing albicanol and/or drimenol
[patent_app_type] => utility
[patent_app_number] => 17/673465
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20895
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673465 | Method for producing albicanol and/or drimenol | Feb 15, 2022 | Issued |
Array
(
[id] => 19609599
[patent_doc_number] => 12158471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Recombinant amebocyte lysate and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/650803
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 18899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650803 | Recombinant amebocyte lysate and uses thereof | Feb 10, 2022 | Issued |
Array
(
[id] => 17800405
[patent_doc_number] => 11414690
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-16
[patent_title] => Uridine diphosphate glycosyltransferase and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/650591
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10475
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650591 | Uridine diphosphate glycosyltransferase and use thereof | Feb 9, 2022 | Issued |